ANI Pharmaceuticals | ANIP - Operating Profit


ANI Pharmaceuticals reported $29.13M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 521M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Perrigo USD 84.4M 9M Dec/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025